- Longevity biotech Minovia plans $180m SPAC
- Lab tests raise concerns over longevity supplements label accuracy
- Semaglutide linked to reduced dementia risk in 1.7 million patients
- Should every drug go through mouse lifespan studies?
- Dual Threats From Trump and GOP Imperil Nursing Homes and Their Foreign-Born Workers
- Scientists reveal your morning coffee flips an ancient longevity switch
- Dogs, data and the drive to decode aging
- OutSee lands funding to harness predictive genomics in drug discovery
- Prize aims to drive AI into the heart of ALS drug discovery
- The brain’s sweet spot: How criticality could unlock learning, memory—and prevent Alzheimer’s
- Vitamin C flips your skin’s “youth genes,” reversing age-related thinning
- 1. 7 million patients reveal stunning link between semaglutide and lower dementia risk
- The molecule that might save your sight—and your heart
- Popular weight-loss drug shows promise in reducing dementia risk for seniors with diabetes, major study finds
- New study uncovers three big factors for boosting physical activity among older adults
- Research: Playing cards and volunteering may be keys to healthy aging
- Clinical briefs for Wednesday, June 25
- Flightless honor flights offer veterans honor flights with feet still firmly on the ground
- Finck-Boyle named senior vice president of AAPACN
- Coronary laser takes aim at calcified arteries in aging patients
- Infinity Bio lands funding to harness the ‘reactome’ against disease
- COVID-19 protein triggers immune attacks on healthy cells — but a common drug can stop it
- Staffing mandate knockout embodies ‘evolution’ to new rule-making era
- UPDATED: Providers ‘hopeful’ but ‘skeptical’ as feds announce insurers, MA plans will limit prior authorization use
- EEOC lawsuit alleges nursing home discriminated against workers over 40
- Also in the News for Tuesday, June 24
- Hypertension is most common chronic condition among Americans 85 and older, CDC study reveals
- Food insecurity linked to gut microbiome changes that increase cognitive impairment risk
- Medicare Advantage marketing practices raise concerns for kidney disease patients
- Clinical briefs for Tuesday, June 24